Treatment of Tachycardia in Hypertension: Where Do We Stand Now?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6506|1|2|129-140

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.1, Iss.2, 2005-06, pp. : 129-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Challenges of RSV Vaccines. Where do we Stand?

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 99-108

Bentham Science Publishers

Access to resources Recommend Favorite

Imaging Subclinical Atherosclerosis: Where Do We Stand?

By  

Current Cardiology Reviews, Vol. 13, Iss. 1, 2016-11 ,pp. : 47-55

Bentham Science Publishers

Access to resources Recommend Favorite

Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?

By  

Current Vascular Pharmacology, Vol. 16, Iss. 1, 2018-01 ,pp. : 30-43

Bentham Science Publishers

Access to resources Recommend Favorite

Omega 3: Where Do We Stand?

By Versari Daniele   Daghini Elena   Salvetti Guido   Salvetti Antonio  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 4, 2008-01 ,pp. : 225-230

Adis International

Access to resources Recommend Favorite

4 years after withdrawal of rofecoxib: where do we stand today?

By Jaksch W.  

Rheumatology International, Vol. 28, Iss. 12, 2008-10 ,pp. : 1187-1195

Springer Publishing Company

Access to resources Recommend Favorite